Zeria Pharmaceutical Co Ltd


Zeria Pharmaceutical Co Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,226.00
  • Today's Change-16.00 / -0.71%
  • Shares traded50.40k
  • 1 Year change+16.00%
  • Beta0.4695
Data delayed at least 20 minutes, as of Nov 30 2022 06:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 4559:TYO price reached a new 52-week high of 2,295.00 at 09:00 GMT
  • 4559:TYO trading volume exceeds daily average by +36.29%
  • 4559:TYO price reached a new 52-week high of 2,282.00 at 09:29 GMT
  • 4559:TYO price moved over +1.02% to 2,279.00

Key statistics

On Wednesday, Zeria Pharmaceutical Co Ltd (4559:TYO) closed at 2,226.00, -3.09% below its 52-week high of 2,297.00, set on Nov 28, 2022.
52-week range
1,837.00Jan 27 20222,297.00Nov 28 2022
Markit short selling activity
Previous close2,242.00
Average volume49.24k
Shares outstanding53.12m
Free float38.99m
P/E (TTM)17.08
Market cap119.09bn JPY
EPS (TTM)131.27
Annual div (ADY)36.00
Annual div yield (ADY)1.58%
Div ex-dateSep 29 2022
Div pay-dateDec 01 2022
Next div ex-dateMar 30 2023
Next div pay-date--
Data delayed at least 20 minutes, as of Nov 30 2022 06:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.